Immune response and immunotherapy in intraepithelial and invasive lesions of the uterine cervix

Clinical and Experimental Obstetrics and Gynecology

Volumn 39, Issue 1, 2012, Pages 27-31

  Machado, F A ^a   Janssens, J Ph ^b   Michelin, M A ^a   Murta, E F C ^c  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b HASSELT UNIVERSITY   (Belgium)

^c Federal University of the Triangulo Mineiro UFTM   (Brazil)

Author keywords

Cervical intraepithelial neoplasia; Human papillomavirus; Immunotherapy; Interferon and dendrite cells

Indexed keywords

CYTOKINE; INTERFERON; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; MACROPHAGE; NONHUMAN; REVIEW; TUMOR CELL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; IMMUNOTHERAPY; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 84860868106     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Brasil. Instituto Nacional do Câncer. Estimativa 2008 Incidência de Câncer no Brasil. Disponível em: 〈http://www.inca.gov.br/estimativa/2008/〉
2. Harro C.D., Pang R.B.S., Roden A., Hildesheim Z., Wang M.J., Reynolds T.C. et al.: "Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine". J. Natl. Cancer Inst., 2001, 93, 284.
3. Neves K., Fonseca C.S., Mendonça M.: "Lesão escamosa intraepitelial de alto grau do colo uterino: aspectos epidemiológicos e diagnósticos". J. Bras Med., 2005, 89, 63.
4. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M. et al.: "The 2001 Bethesda System: terminology for reporting results of cervical cytology". JAMA, 2002, 287, 2114.
5. Bäfverstedt B.: "Condylomata acuminata - past and present". Acta Derm. Venerol., 1967, 47, 376.
6. De Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., Zur Hausen H.: "Classification of papillomaviruses". Virology, 2004, 324, 17.
7. Stanley M.A.: "Immunobiology of HPV and HPV vaccines". Gynecol. Oncol., 2008, 709, S15.
8. Burd M.E.: "Human papillomavirus and cervical cancer". Clin. Micribiol., 2003, 16, 1.
9. Franco E.L.: "Cancer causes revisited: human papillomavirus and cervical neoplasia". J. Natl. Cancer Inst., 1995, 87, 779.
10. Khan M.J., Castle P.E., Lorincz A.T., Wacholder S., Sherman M., Scott D.R. et al: "The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice". J. Natl. Cancer Inst., 2005, 97, 1072.
11. Koutsky L.A., Galloway D.A., Holmes K.K.: "Epidemiology of genital human papillomavirus infection". Epidemiol. Rev., 1988, 10, 122.
12. Zehbe I., Rylander E., Edlund K., Wadell G., Wilander E.: "Detection of human papillomavirus in cervical intraepithelial neoplasia, using in situ hybridization and various polymerase chain reaction techniques". Virchows Arch., 1996, 428, 151.
13. Merkelbach-Bruse S., Jakob C., Tietze L., Schröder W., Rath W., Füzesi L.: "Consensus polymerase chain reaction and enzyme-linked immunosorbent assay for human papillomavirus detection and typing in cervical specimens". Diagn. Mol. Pathol., 1999, 8, 32.
14. Ley C., Bauer H.M., Reingold A., Schiffman M.H., Chambers J.C., Tashiro C.J. et al.: "Determinants of genital human papillomavirus infection in young women". J. Natl. Cancer Inst., 1991, 83, 997.
15. Melken P.W., Hopman E., van den Brule A.J., Risse E.K., van Diest P.J., Bleker O.P. et al.: "Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent". Int. J. Cancer, 1993, 53, 919.
16. Jordão A.V., Ruggeri L.S., Chiucheta G.I.R., Piva S., Consolaro M.E.L.: "Importância da aplicação de critérios morfológicos não clássicos para o diagnóstico citomorfológico de papilomavírus humano". J. Bras. Pat. Med. Lab., 2003, 39, 81.
17. Nomelini R.S., Barcelos A.C.M., Michelin M.A., Adad S.J., Murta E.F.G: "Utilization of human papillomavirus testing for cervical cancer prevention in a university hospital". Cad Saúde Pública, 2007, 23, 1309.
18. Terra A.P.S., Murta E.F.G, Maluf P.J., Caballero O.L.S.D., Brait M., Adad S.S.: "Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III". Tumori, 2007, 93, 572.
19. Kohlberger P., Gitsch G.: "Immunology of cervical cancer". CME J. Gynecol. Oncol., 2001, 6, 383.
20. Clerici M., Shearer G.M., Clerici E.: "Cytokine dysregulation in invasive cervical carcinoma and other human neopplasias : time to consider the Th1/Th2 paradigm". J. Natl. Cancer Inst., 1998, 90, 261.
21. rd ed. London: Garland, 1997.
22. Uthaisangsook S., Day N.K., Bahna S.L., Good R.A., Haraguchi S.: "Innate immunity and its role against infections". Ann. Allergy Asthma Immunol, 2002, 88, 253.
23. Stiepcich M.: "O papel do HPV no cancer cervical". Dis. Markers, 2000, 17, 123.
24. st ed. Guanabara Koogan: Rio de Janeiro, 1992.
25. Michelin M.A., Murta E.F.G: "Potential therapeutic vaccine strategies and relevance of immune system in uterine cervical cancer". Eur. J. Gynecol. Oncol., 2008, 29, 10.
26. Ansel J., Perry P., Brown J., Damm D., Phan T., Hart C. et al.: "Cytokine modulation of keratinocyte cytokines". J. Invest. Dermatol, 1990, 94, 101S.
27. Kyo S., Inoue M., Hayasaka N., Inoue T., Yutsudo M., Tanizawa O. et al.: "Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines". Virology, 1994, 200, 130.
28. Sharma A., Rajappa M., Saxena A., Sharma M.: "Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix". Int. J. Gynecol. Cancer, 2007, 17, 879.
29. Gonda T.A., Tu S., Wang T.C.: "Chronic inflammation, the tumor microenvironment and carcinogenesis". Cell. Cycle, 2009, 8, 2005.
30. Stanley M.A.: "Immunobiology of papillomavirus infeccions". J. Reprod. Immunol, 2001, 52, 45.
31. Tindle R.W.: "Immune evasion in human papillomavirus-associated cervical cancer". Nature Rev. Cancer, 2002, 2, 59.
32. Stern P.L., Brown M., Stacey S.N., Kitchener H.C., Hampson I., Abdel-Hady E.S. et al: "Natural HPV immunity and vaccination strategies". J. Clin. Virol., 2000, 19, 57.
33. Konya J., Dillner J.: "Immunity to oncogenic human papillomaviruses". Adv. Cancer Res., 2001, 82, 205.
34. Maluf P.J., Michelin M.A., Etchebehere R.M., Adad S.J., Murta E.F.C.: "T lymphocytes (CD3) may participate in the recurrence of cervical intraepithelial neoplasia grade III". Arch. Gynecol. Obstet., 2008, 278, 525.
35. Tavares-Murta B.M., De Resende A.D., Cunha F.Q., Murta E.F.C.: "Local profile of cytokines and nitric oxide in patients with bacterial vaginosis and cervical intraepithelial neoplasia". Eur. J. Obstet. Gynecol. Reprod. Biol., 2008, 138, 93.
36. Fernandes P.C. Jr., Garcia C.B., Micheli D.C., Cunha F.Q., Murta E.F.C., Tavares-Murta B.M.: "Circulating neutrophils may play a role in the host response in cervical cancer". Int. J. Gynecol. Cancer, 2007, 17, 1068.
37. Robertson M.: "Innate immunity". Curr. Biol., 1998, 8, R595.
38. Agrawal T., Vats V., Wallace P.K., Salhan S., Mittal A.: "Role of cervical dendritic cell subsets, co-stimulatory molecules, cytokine secretion profile and beta-estradiol in development of sequalae to Chlamydia trachomatis infection". Reprod. Biol. Endocrinol., 2008, 6, 46.
39. Quayle A.J.: "The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells". J. Reprod. Immunol., 2002, 57, 61.
40. Alcocer-Gonzalez J.M., Berumen J., Tamez-Guerra R., Bermúdez- Morales V., Peralta-Zaragoza O., Hernández-Pando R. et al.: "In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells". Viral. Immunol., 2006, 19, 481.
41. Tartour E., Gey A., Sastre-Garau X., Lombard Surin I., Mosseri V., Friedman W.H.: "Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas". J. Natl. Cancer Inst., 1998, 90, 287.
42. Sheu B.C., Chiou S.H., Lin H.H., Chow S.N., Huang S.C., Ho H.N. et al.: "Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma". Cancer Res., 2005, 65, 2921.
43. Murta E.F.C.: "Vacina contra o HPV ou contra o câncer de colo uterino?". Rev. Bras. Ginecol. Obstet., 2007, 29, 548.
44. Murta E.F., Tavares-Murta B.M.: "Successful pregnancy after vaginal cancer treated with interferon". Tumori, 2004, 90, 247.
45. Ferrantini M., Capone I., Belardelli F.: "Dendritics cells and cytokines in immune rejection of cancer". Cytokine & Growth Factor., 2008, 19, 93.
46. Haller O., Kochs G., Weber F.: "The interferon response circuit: induction and suppression by pathogenic viruses". Virology, 2006, 344, 119.
47. Randall R.E., Goodbourn S.: "Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures". J. Gen. Virol., 2008, 89, 1.
48. Ank N., West H., Paludan S.R.: "IFN-lambda: novel antiviral cytokines". J. Interferon Cytokine Res., 2006, 26, 373.
49. Uzé G., Monneron D.: "IL-28 and IL-29: newcomers to the interferon family". Biochimie, 2007, 89, 729.
50. Borden E.C., Sen G.C., Uze G., Silverman R.H., Ransohoff R.M., Foster G.R. et al.: "Interferons at age 50: past, current and future impact on biomedicine". Nat. Rev. Drug. Discov., 2007, 6, 975.
51. Nomelini R.S., Mardegan M.C., Murta E.F.C.: "Utilization of interferon in gynecologic and breast cancer". Clin. Med. Oncol., 2007, 1, 111.
52. De Lorenzo B.H., Ramos M.C., Michelin M.A., Murta E.F.C.: "Progress in the use of immunotherapy to treat uterine cervical cancer". Tumori, 2009, 95, 1.
53. Steinman R.M., Hawiger D., Nussenzweig M.C.: "Tolerogenic dendritic cells". Annu. Rev. Immunol., 2003, 21, 685.
54. Santin A.D., Bellone S., Palmieri M., Ravaggi A., Romani C., Tassi R. et al.: "HPV 16/18 E7 - pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities". Gynecol. Oncol., 2006, 100, 469.
55. Zijlmans H.J., Fleuren G.J., Baelde H.J., Eilers P.H., Kenter G.G., Gorter A.: "Role of tumor-derived proinflammatory cytokines GM-CSF, TNF-alpha, and IL-12 in the migration and differentiation of antigen presenting cells in cervical carcinoma". Cancer, 2007, 109, 556.